Tanvex BioPharma Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Tanvex BioPharma Inc

Watchlist Manager

Watchlist

Price: 30.25 TWD -2.73% Market Closed

Market Cap: NT$8B

	Tanvex BioPharma Inc TWSE:6541	KY
B	BHP Group Ltd DUS:BHP1	AU
N	Nissan Chemical Corp XMUN:NSC	JP

Profitability Summary

Tanvex BioPharma Inc's profitability score is 16/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-142%

Negative 3Y Average Gross Margin

-6%

Declining Gross Margin

88% > -142%

Negative Operating Margin

-285%

Negative 3Y Average Operating Margin

-2.676%

Operating Margin is Increasing

-3.441% > -285%

Negative Net Margin

-294%

Negative 3Y Average Net Margin

-2.732%

Net Margin is Increasing

-3.482% > -294%

Negative Free Cash Flow Margin

-385%

Negative 3Y Average Free Cash Flow Margin

-2.228%

Free Cash Flow Margin is Increasing

-2.323% > -385%

Negative ROE

-26%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-52%

ROIC is Increasing

-77% > -20%

View All

Hide

Collapse

16 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.